Trials / Completed
CompletedNCT00149188
Somatuline Autogel: Acromegaly Self/Partner Injection Study
A Phase IV, Multicentre, Open Label, Controlled Study to Assess the Ability of Patients With Acromegaly, or Their Partners, to Administer Somatuline Autogel.
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Ipsen · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to allow patients with acromegaly, or their partners, to learn how to successfully inject Somatuline Autogel at home. Ability to perform unsupervised injections whilst maintaining adequate disease control will be assessed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Lanreotide (Autogel formulation) |
Timeline
- Start date
- 2004-02-01
- Primary completion
- 2005-08-24
- Completion
- 2005-08-24
- First posted
- 2005-09-08
- Last updated
- 2019-08-05
Locations
10 sites across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT00149188. Inclusion in this directory is not an endorsement.